This article is part of a Chronicle. See more from this Chronicle Kent Bernard, Feb 23, 2009 You could posit several fairly obvious reasons for the perceived lack of new…

In this issue: The EC Pharmaceutical Sector Inquiry   Kent Bernard, Feb 23, 2009 Solving the Wrong Problem The Preliminary Report on the EC Pharmaceutical Sector Inquiry: What Have We…

This article is part of a Chronicle. See more from this Chronicle Luc Gyselen, Feb 26, 2009 This article will focus on the Commission’s antitrust enforcement agenda and examine two…

This article is part of a Chronicle. See more from this Chronicle David Hull, Feb 25, 2009 Much of the discussion at the time of the Report’s release and since…

This article is part of a Chronicle. See more from this Chronicle Anthony Dawes, James Killick, Feb 24, 2009 On November 28, 2008, DG Competition’s (“DG COMP”) published its Preliminary…

This article is part of a Chronicle. See more from this Chronicle Susan Creighton, Seth Silber, Feb 24, 2009 This commentary explores the potential impact of the [Pharmaceutical] Report in…

This article is part of a Chronicle. See more from this Chronicle Kristina Nordlander, Stephen Spinks, Feb 24, 2009 In the presentation of its Preliminary Report on the pharmaceutical sector…

This article is part of a Chronicle. See more from this Chronicle Elena Kamilarova, Dominik Schnichels, Feb 24, 2009 On November 28, 2008 the European Commission published its preliminary findings…